It is a sad fact that despite being almost completely preventable through human
papillomavirus (HPV) vaccination and screening, cervical cancer remains the fourth most …

Human papillomavirus (HPV) is the most common sexually transmitted virus worldwide.
More than 99% of cervical cancer cases are associated with certain types of HPVs, termed …

Human papillomavirus (HPV) infection is the cause of a growing percentage of head and
neck cancers (HNC); primarily, a subset of oral squamous cell carcinoma, oropharyngeal …

In the tumor microenvironment (TME), tumor cells are constantly evolving to reduce
neoantigen generation and the mutational burden to escape the anti-tumor response. This …

Immunotherapy for cervical cancer should target high-risk human papillomavirus types 16
and 18, which cause 50% and 20% of cervical cancers, respectively. Here, we describe the …

Cervical cancer, caused by human papillomavirus (HPV), is the fourth most common type of
cancer among women worldwide. While HPV prophylactic vaccines are available, they have …

Vaccines are one of the most effective medical interventions to combat newly emerging and
re-emerging diseases. Prophylactic vaccines against rabies, measles, etc., have excellent …

Human papillomavirus (HPV) is a viral infection with skin-to-skin based transmission mode.
HPV annually caused over 500,000 cancer cases including cervical, anogenital and …

Chronic infection by high-risk human papillomaviruses (HPV) and chronic inflammation are
factors associated with the onset and progression of several neoplasias, including cervical …

Human papillomavirus (HPV) is the most common sexually transmitted infection, currently
affecting close to 80 million Americans. Importantly, HPV infection is recognized as the …